Federally-Listed PSOs

Below is a list of PSOs that are currently listed by AHRQ. A health care provider can only obtain the confidentiality and privilege protections of the Patient Safety Act by working with a Federally-listed PSO.

Use the categories on the left to filter the list of PSOs or search a PSO name.

Note: AHRQ updates the PSO information contained within the directories weekly, as needed; changes are made when there are newly listed PSOs and/or when existing information requires revision. Changes that would otherwise be effective on a weekend day or holiday will be effective on the next business day. Information contained in the directories is based on attestations that the PSOs provide. To update PSO contact information, please use the Change of Listing Information form; to update profile information, please go to the PSO PPC Web site.

There are 83 total PSOs listed by AHRQ.

Alliance for Patient Medication Safety - P0020
Component of Parent Org(s):
  • NASPA
Effective Date and Time of Initial Listing: December 10, 2008 12:01 AM ET
Street Address: 2530 Professional Road, Suite 202, Richmond, Virginia 23235
PSO Phone Number: (804) 422-6311
Point of Contact: Taramarie (Tara) Modisett
Point of Contact Phone: (804) 422-6311
Point of Contact Email: tara@naspa.us (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 12/10/2018 through 12/09/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
American Medical Foundation Patient Safety Organization - P0141
Component of Parent Org(s):
  • American Medical Foundation for Peer Review and Education
Effective Date and Time of Initial Listing: March 13, 2013 12:01 AM ET
Street Address: 237 S. 18th Street, 11th Floor, 11D, Philadelphia, Pennsylvania 19103
PSO Phone Number: 215-545-6363
Point of Contact: Evelyn Baram-Clothier Ph.G, JD
Point of Contact Phone: 215-545-6363
Point of Contact Email: ebc@medicalfoundation.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 03/13/2021 through 03/12/2023
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Child Health Patient Safety Organization, Inc. - P0119
Component of Parent Org(s):
  • National Association of Children's Hospitals (N.A.C.H.)
Effective Date and Time of Initial Listing: October 12, 2011 12:01 AM ET
Street Address: 16011 College Blvd, Suite 250, Lenexa, Kansas 66219
PSO Phone Number: (913) 981-4118
Point of Contact: Barbara Weis
Point of Contact Phone: (913) 981-4117
Point of Contact Email: barbara.weis@childrenshospitals.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 10/12/2017 through 10/11/2019
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Clarity PSO - P0015
Component of Parent Org(s):
  • Clarity Group, Inc.
Effective Date and Time of Initial Listing: November 19, 2008 12:01 AM ET
Street Address: 8725 W Higgins Road, Suite 810, Chicago, Illinois 60631
PSO Phone Number: (773) 867-8066
Point of Contact: Thomas F. Piotrowski
Point of Contact Phone: (773) 867-8066
Point of Contact Email: tpiotrowski@claritypso.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 11/19/2018 through 11/18/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
DARTNet Institute Patient Safety Organization - P0176
Component of Parent Org(s):
  • DARTNet Institute
Effective Date and Time of Initial Listing: December 22, 2015 12:01 AM ET
Street Address: 12635 East Montview Blvd, Aurora, Colorado 80045
PSO Phone Number: 800-434-0278
Point of Contact: Danica Schrader
Point of Contact Phone: (720) 232-6153
Point of Contact Email: Danica.Schrader@dartnet.info (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 12/22/2017 through 12/21/2019
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
ECRI Institute PSO - P0008
Component of Parent Org(s):
  • ECRI Institute
Effective Date and Time of Initial Listing: November 5, 2008 12:01 AM ET
Street Address: 5200 Butler Pike, Plymouth Meeting, Pennsylvania 19462
PSO Phone Number: 866-247-3004
Point of Contact: William M. Marella
Point of Contact Phone: (610) 825-6000, ext. 5173
Point of Contact Email: WMarella@ECRI.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 11/05/2018 through 11/04/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Emergency Consultants PSO, LLC (d/b/a ECI PSO, LLC) - P0069
Component of Parent Org(s):
  • ECI Healthcare Partners, LLC
Effective Date and Time of Initial Listing: June 17, 2009 12:01 AM ET
Street Address: 4075 Copper Ridge Drive, Traverse City, Michigan 49684
PSO Phone Number: (231) 946-6200
Point of Contact: Mark A. Burnheimer Esq.
Point of Contact Phone: (231) 946-6200
Point of Contact Email: mab@bc-legal.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 06/17/2019 through 06/16/2021
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Health Catalyst Patient Safety Organization (HCPSO) - P0201
Component of Parent Org(s):
  • Health Catalyst, Inc
Effective Date and Time of Initial Listing: July 24, 2018 12:01 AM ET
Street Address: 3165 E Millrock Dr. Suite 400, Salt Lake City, Utah 84121
PSO Phone Number: (801) 708-6800
Point of Contact: Robert Michael Barton PharmD
Point of Contact Phone: 801-708-6800
Point of Contact Email: michael.barton@healthcatalyst.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 07/24/2018 through 07/23/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Institute for Safe Medication Practices (ISMP) - P0009
Effective Date and Time of Initial Listing: November 5, 2008 12:01 AM ET
Street Address: 200 Lakeside Drive, Suite 200, Horsham, Pennsylvania 19044
PSO Phone Number: (215) 947-7797
Point of Contact: Ann D. Shastay RN, MSN, AOCN
Point of Contact Phone: (215) 947-7797
Point of Contact Email: ashastay@ismp.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 11/05/2020 through 11/04/2022
Disclosures & Finding: None
LifePoint PSO, LLC - P0180
Component of Parent Org(s):
  • LifePoint Hospitals Holdings, LLC
Effective Date and Time of Initial Listing: August 16, 2016 12:01 AM ET
Street Address: 330 Seven Springs Way, Brentwood, Tennessee 37027
PSO Phone Number: 615-920-7869
Point of Contact: Amy Beitler RN
Point of Contact Phone: 615-920-7515
Point of Contact Email: Amy.Beitler@LPNT.net (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 08/16/2019 through 08/15/2021
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
QA to QI LLC - P0091
Effective Date and Time of Initial Listing: June 30, 2010 12:01 AM ET
Notification to Providers: This PSO's three-year listing expires within 60 days, and AHRQ has not yet received its application for continued listing.
Street Address: 2912 Blueberry Lane, Chapel Hill , North Carolina 27516
PSO Phone Number: (860) 521-8484
Point of Contact: Marc T Edwards MD, MBA
Point of Contact Phone: (860) 521-8484
Point of Contact Email: Marc@QAtoQI.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 06/30/2018 through 06/29/2020
Disclosures & Finding:
SimCore PSO, LLC - P0189
Component of Parent Org(s):
  • SimCore Technologies, Inc.
Effective Date and Time of Initial Listing: November 29, 2016 12:01 AM ET
Street Address: 1434 Spruce Street Suite 118, Boulder, Colorado 80304
PSO Phone Number: (888) 584-8845
Point of Contact: Brian Gillett
Point of Contact Phone: 888-584-8845
Point of Contact Email: pso@simcorepso.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 11/29/2018 through 11/28/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Society for Vascular Surgery Patient Safety Organization, LLC - P0106
Component of Parent Org(s):
  • Society for Vascular Surgery
Effective Date and Time of Initial Listing: February 16, 2011 12:01 AM ET
Street Address: 633 North Saint Clair Street, 22nd Floor, Chicago, Illinois 60611
PSO Phone Number: (800) 258-7188
Point of Contact: James K. Wadzinski
Point of Contact Phone: 312-334-2311
Point of Contact Email: jwadzinski@vascularsociety.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 02/16/2019 through 02/15/2021
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
The Envision Healthcare Center for Quality and Patient Safety, LLC - P0197
Component of Parent Org(s):
  • Envision Healthcare
Effective Date and Time of Initial Listing: October 19, 2017 12:01 AM ET
Street Address: 1A Burton Hills Boulevard, Nashville, Tennessee 37215
PSO Phone Number: (615) 665-3558
Point of Contact: Debbie Cibulka
Point of Contact Phone: 615-665-3558
Point of Contact Email: deborah.cibulka@shcr.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 10/19/2019 through 10/18/2021
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
The PSO Advisory, LLC - P0089
Effective Date and Time of Initial Listing: May 5, 2010 12:01 AM ET
Street Address: 30 Cargill Rd, Cumberland, Rhode Island 02864
PSO Phone Number: (401) 228-7590
Point of Contact: William P Smith RPH, MS
Point of Contact Phone: 401-228-7590
Point of Contact Email: wpsmith@thepsoadvisory.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 05/05/2018 through 05/04/2020
Disclosures & Finding: None
Vizient™ PSO - P0007
Component of Parent Org(s):
  • Vizient Inc
  • Vizient™ Data Services, LLC
Effective Date and Time of Initial Listing: November 5, 2008 12:01 AM ET
Street Address: 155 North Wacker Drive, 40th floor, Chicago, Illinois 60606
PSO Phone Number: 312-775-4100
Point of Contact: Ellen M. Flynn RN, MBA, JD
Point of Contact Phone: (312) 775-4292
Point of Contact Email: Ellen.Flynn@vizientinc.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 11/05/2020 through 11/04/2022
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No